HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in HCW Biologics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q1 2024
- Shares held
- 1.21M
- +112.4K (+10.2%) vs. Q1 2024
- Total value
- $784.3K
- −$1.11M (−58.7%) vs. Q1 2024
- New holders
- 1
- 7 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HCWB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $515.7K |
| Q1 2026 | 15 | $160.8K |
| Q4 2025 | 14 | $424.1K |
| Q3 2025 | 10 | $456.9K |
| Q2 2025 | 8 | $85.5K |
| Q1 2025 | 15 | $326.0K |
| Q4 2024 | 18 | $1.40M |
| Q3 2024 | 16 | $625.6K |
| Q2 2024 | 19 | $784.3K |
| Q1 2024 | 20 | $1.90M |
| Q4 2023 | 19 | $1.30M |
| Q3 2023 | 14 | $1.93M |
| Q2 2023 | 13 | $2.17M |
| Q1 2023 | 13 | $1.22M |
| Q4 2022 | 14 | $1.50M |
| Q3 2022 | 13 | $1.50M |
| Q2 2022 | 13 | $1.25M |
| Q1 2022 | 13 | $1.48M |
| Q4 2021 | 13 | $855.0K |
| Q3 2021 | 9 | $512.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding HCW Biologics Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avantax Planning Partners, Inc. | 279,541 | $180.9K | 0.01% | +99,764+55.5% | Added |
| HighTower Advisors, LLC | 180,810 | $117.0K | 0.00% | +1,000+0.6% | Added |
| Geode Capital Management, LLC | 170,385 | $110.3K | 0.00% | −3,899−2.2% | Reduced |
| Cresset Asset Management, LLC | 131,990 | $85.4K | 0.00% | 00.0% | Unchanged |
| Pullen Investment Management, LLC | 85,116 | $55.1K | 0.05% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 84,700 | $54.8K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 66,659 | $43.0K | 0.00% | −6,454−8.8% | Reduced |
| BlackRock Inc. | 42,662 | $27.6K | 0.00% | −3,372−7.3% | Reduced |
| Vanguard Group Inc | 37,677 | $24.4K | 0.00% | +28+0.1% | Added |
| AE Wealth Management LLC | 30,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 24,137 | $15.6K | 0.00% | +6,890+39.9% | Added |
| Two Sigma Investments, LP | 22,480 | $14.5K | 0.00% | −160−0.7% | Reduced |
| State Street Corp | 21,446 | $13.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,876 | $8.98K | 0.00% | +13,876 | New |
| Northern Trust Corp | 10,205 | $6.60K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,212 | $4.02K | 0.00% | +1,274+25.8% | Added |
| UBS Group AG | 4,285 | $2.77K | 0.00% | +3,680+608.3% | Added |
| Bank of America Corp | 156 | $101 | 0.00% | −250−61.6% | Reduced |
| Royal Bank of Canada | 407 | $0 | 0.00% | +163+66.8% | Added |
| Wells Fargo & Company | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |